@RAEngNews Research Fellow applying control theory to the design of gene circuits/metabolic pathways in #synbio #biotech #engbio Also apsduk.bsky.social
X: Thrilled to release a new preprint on the development of an AI-powered cloud biofoundry for autonomous biological research on bioRxiv (biorxiv.org/content/10.64898…). By integrating agentic AI with physical AI, iCloudBiofoundry provides a cloud accessible, self-evolving, and scalable platform that unifies computational design and robotic execution. Congrats to an outstanding group of students and postdocs from @HuiminZhaoLab and a couple of staff scientists from @NCSAatIllinois. Hope the iCloudBiofoundry platform will unleash a new era in scientific research just like what NCSA Mosaic transformed the Internet in 1993.
Do you use GFP to measure protein abundance? Be very careful. Our new bioRxiv preprint shows that, under translation inhibition, fluorescence can stop tracking how much reporter protein is actually there.
Please share widely.
1/5
Bioengineering succeeds or fails as a system, not as a collection of optimized parts. From closed-loop devices to cell therapies, systems engineering can help convert independently optimized components into robust, validated and usable technologies.
bit.ly/4bneQLq
There is something fundamentally wrong in the idea that we can just force biological systems to stably run computations with the same logic of our machines. Instead of trying to suppress context-dependency, noise & evolution we should embrace them for designing robust biosystems
Richard Murray, a professor at Caltech, made this beautiful chart showing how the complexity of gene circuits (as measured by their number of "parts," or components) has scaled over time. (I'm sharing it below with permission.)
We can learn many things from this chart.
First, academic laboratories have been able to make some *really* complicated gene circuits. My friend, Jai Padmakumar, made the largest gene-circuit ever reported; it was described in a 2024 paper. Jai assembled 1.1 million bases of synthetic DNA into 110 distinct logic gates, and then partitioned that DNA across 66 strains of E. coli. Together, these engineered cells could compute the MD5 hashing algorithm.
The problem is that the larger you make your gene circuit, the less "robust" or reliable the engineered cell becomes. Living organisms did not evolve to carry human-made gene circuits! Therefore, many synthetic biology efforts fail to scale into the real-world. The more complex a gene circuit, or the more genes it has, the less likely that it will be robust over time. More genes have more opportunities to break.
(Note that this is not always the case in natural organisms. Many cells have evolved overlapping ways to regulate genes, such that if one breaks, others can fill in the gap. We're not good at emulating this synthetically, though.)
The chart below shows this trend via the red, dotted line. Engineered cells that have been *commercialized* tend to have only a small number of engineered components; usually less than 10 synthetic genes in total. There is a drop-off in number of components as we move from the laboratory to the real-world.
How can synthetic biologists solve this, and begin to build large gene circuits that are robust over time?
Perhaps we should make it standard to grow engineered cells in a small bioreactor, perturb them with various stressors, and see how well the engineered cells hold up over time. We could record the number of generations that pass before a cell's functions break, and then report that value in the paper. (This is sometimes done, but not often.)
Another option is to "merge" human-made designs, or AI-generated DNA, with continuous evolution.
If we wanted to engineer a cell to break down plastic and recycle the atoms into a medicine, for example, then we could first build dozens of different gene circuit architectures (using high-throughput DNA assembly methods), put each gene circuit into a cell, and then do continuous evolution on each of them to see which one holds up best over time, with various stressors. We could sequence the populations over time, see which sequences hold up well, and use the data to train predictive models of "cellular robustness."
Some time ago I joined Karmella Hayne and Elyzabeth Wayne in curating a Special issue on Mammalian cell Synthetic Biology.
Glad our editorial is now out! Check it out at doi.org/10.1021/acssynbio.6c…
What a great day and place to have a conference! Thank >227 attendees for participating in #SynBYSS Barcelona conference! A snap shot taken when people are still discussing research, not looking at the camera, showing complexity and diversity of engineering biology.
@marcguellc
The abstract submission deadline for Biocontrol26 is coming up Friday May 15th! @bioctrl 🦠🎮
If you are interested in giving a talk or presenting a poster in September at Oxford, you can submit an abstract and see more information on our website:
biocontrolseminars.org/bioco…